Oral Administration

Oral treatment

Oral Contraceptives

Oral appliances

Oral antihyperglycemic drugs

CDC No Longer Recommends Oral Cephalosporins for Gonorrhea

For uncomplicated gonorrhea, the CDC now recommends treatment with ceftriaxone 250 mg intramuscularly and either oral single-dose azithromycin 1 g or oral doxycycline 100 mg twice daily for 7 days....

Pfizer announces availability of Quillivant XR™ CII for extended-release oral suspension in the United States

Quillivant XR™ CII for extended-release oral suspension is now available...

FDA approves Lupin NDA for SUPRAX Oral Suspension, 500 mg/5mL

The US Food and Drug Administration (FDA) has approved Lupin Pharmaceuticals' new drug application (NDA) for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL.

Tamiflu oral suspension concentration halved to 6mg/ml

Tamiflu oral suspension’s concentration is being halved from 12mg/ml to 6mg/ml to help reduced the potential for dosing errors...

Pfizer: Quillivant XR CII For Extended-release Oral Suspension Available In U.S.

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced that Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension is now available in the U.S. for the treatment of ...

Azithromycin for Bronchial Asthma in Adults

How effective is azithromycin in treating chronic asthma in adults? Journal of the American Board of Family Medicine

Azithromycin does not look cardiotoxic in a general population

N Engl J Med2013;368:1704-12Concerns were raised last year about a small excess of deaths from cardiovascular disease in US adults taking azithromycin, so Danish researchers looked for a similar......

HIV/AIDS Update - Prezista (darunavir) tablet and oral suspension: pediatric dosing

On February 1, 2013, FDA approved revisions to the Prezista (darunavir) tablet and oral suspension label to include once daily dosing in treatment-naïve subjects 3 to less than 18 years of age an...

Azithromycin 1.5% ophthalmic solution: in purulent bacterial or trachomatous conjunctivitis.

The second-generation macrolide azithromycin is available as a 1.5% ophthalmic solution for use in the treatment of bacterial or trachomatous conjunctivitis. This article reviews the pharmacological p...

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

The aim of this study was to identify a candidate formulation for further development of a home or near-home administrable paediatric rectal form of a broad-spectrum antibiotic - specially intended fo...

Use of azithromycin and death from cardiovascular causes.

Azithromycin use is associated with an increased risk of death from cardiovascular causes among patients at high baseline risk. Whether azithromycin confers a similar risk in the unselected general po...

Nebulization of mycophenolate mofetil inhalation suspension in rats: Comparison with oral and pulmonary administration of Cellcept(®).

In this study, a suspension of mycophenolate mofetil (MMF) suitable for inhalation was developed using the emulsion template process and characterized for particle size and aerosolization performance....

Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses.

Leclere, M., Magdesian, K. G., Cole, C. A., Szabo, N. J., Ruby, R. E., Rhodes, D. M., Edman, J., Vale, A., Wilson, W. D., Tell, L. A. Pharmacokinetics and preliminary safety evaluation of azithromycin...